Skip links
Companies
› United Kingdom › SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED
SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED logo

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED

Private limited company (Ltd.) Inactive

Registration No.
07260768
Incorporation Date
2010-05-21
Company Type
Private limited company (Ltd.)
Address
Great Abington, Cambridge, United Kingdom
Website
www.synexus.com/
Source: Companies House

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED is a Private limited company (Ltd.) registered in United Kingdom under 07260768, and its current status with Companies House is inactive. The company was incorporated on 21 May 2010 and lists its registered address as Great Abington, Cambridge, United Kingdom. 5 shareholders are on record for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 6 October 2026.

Data Provenance
This record is sourced directly from official government registries, including Companies House.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Five shareholders are currently on record for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.

The largest of these is SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD, holding 33.1% — the largest recorded stake — followed by SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD at 33.1%; the remaining 3 shareholders shown hold smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD 33.1% Companies House
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD 33.1% Companies House
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD 33.1% Companies House
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD 0.3% Companies House
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD 0.3% Companies House

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

Two of the 5 officer records shown for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED are current appointments, filed with Companies House. Julia James (appointed 2016-05-31) and Richard Harris (appointed 2021-12-29) both serve as Director. The remaining 3 records shown (Paul Chambers, Brainard Hartman and 1 other) are former appointments that have since been resigned.

The register reports 16 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

JJ
Julia James ACTIVE

Appointed
2016-05-31
Residence
🇬🇧 United Kingdom
Occupation
Director

RH
Richard Harris ACTIVE

Appointed
2021-12-29
Residence
🇬🇧 United Kingdom
Occupation
Director

PC
Paul Chambers RESIGNED

Appointed
2011-09-23
Resigned
2016-05-31
Residence
🇬🇧 United Kingdom
Occupation
Director

BH
Brainard Hartman RESIGNED

Appointed
2016-05-31
Resigned
2021-12-08
Residence
🇺🇸 United States
Occupation
Director

CN
Christopher Neild RESIGNED

Appointed
2016-05-31
Resigned
2020-03-13
Residence
🇬🇧 United Kingdom
Occupation
Director

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED sits 5 levels below its ultimate parent, Thermo Fisher Scientific Inc., registered in United States. 1 subsidiary is recorded beneath it, across 1 jurisdiction. The full chain up to Thermo Fisher Scientific Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 1 subsidiary spans United Kingdom jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Ultimate HQ
Thermo Fisher Scientific Inc.
United States
SYNEXUS CLINICAL RESEARCH LIMITED+ subsidiaries
United KingdomGB 05575991

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED?

Five shareholders are currently on record for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD, holding 33.1% — the largest recorded stake — followed by SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LTD at 33.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED have on record?

5 shareholders are shown on record for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED.

What is SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's company registration number?

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's registration number is 07260768, filed with Companies House in United Kingdom. Its current status on the register is inactive.

Is SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED still an active company?

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's status on Companies House is listed as inactive, not currently active.

When was SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED incorporated?

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED was incorporated on 21 May 2010, according to Companies House.

What is SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's registered address?

The registered address on file for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED is Great Abington, Cambridge, United Kingdom.

What legal structure is SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED registered as?

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.

Who are the officers/directors of SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED?

Two of the 5 officer records shown for SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED are current appointments, filed with Companies House. Julia James (appointed 2016-05-31) and Richard Harris (appointed 2021-12-29) both serve as Director. The remaining 3 records shown (Paul Chambers, Brainard Hartman and 1 other) are former appointments that have since been resigned. Management authority at SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED have a parent company or subsidiaries?

SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED sits 5 levels below its ultimate parent, Thermo Fisher Scientific Inc., registered in United States. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Those 1 subsidiary spans United Kingdom jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Can Zavia monitor changes to SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's ownership over time?

This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like SYNEXUS CLINICAL RESEARCH MIDCO NO 2 LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Companies House and was last synced on 6 October 2026.

This website uses cookies to improve your web experience.